LCDR Hamilton received a Ph.D. in physical chemistry from Brown University in 2007 followed by a post-doc in Brown University’s Molecular Biology, Cell Biology & Biochemistry Department to study mechanisms and molecular structures generated from site-specific genetic recombination in via Fluorescence Resonance Energy Transfer.
He was commissioned into the U.S. Navy in 2009 and assigned to the Navy’s Drug Lab in San Diego, CA as the Deputy Director of Operations; Chief, Expert Witness Program; and Chief, Scientific Support and Education. His limited research opportunities there focused on novel solid phase extraction techniques for the isolation and chemical analysis of illicit and pharmaceutical drugs in biofluids.
That tour was followed by an academic appointment as assistant professor of chemistry at the U.S. Naval Academy in Annapolis. His research at U.S.N.A. focused on developing analytical GC-MS-EI SIM techniques for improving the detection of certain pharmaceutical compounds in service member samples.
LCDR Hamilton’s most-recent assignment consisted of two critical duties. His first and primary duty was as head of the Genomics & Bioinformatics Department at Naval Medical Research Center’s – Biological Defense Research Directorate (NMRC-BDRD). The 35-person-strong department (Officers, scientists, graduate students, and technicians) applied so-called next generation sequencing (NGS) and bioinformatics to the study of infectious diseases, national biodefense, and global disease surveillance for early pathogen detection and response, as well as the development of novel bacteriophage therapies for multi-drug-resistant bacterial infections in humans. His second duty at BDRD was as a Team Leader of a deployable, highly-mobile laboratory assisting DoD and USG partners with biodefense missions and public health threat response.